Conflicts of interest: none (original) (raw)
Killing of Kras-Mutant Colon Cancer Cells via Rac-Independent Actin Remodeling by the βGBP Cytokine, a Physiological PI3K Inhibitor Therapeutically Effective In Vivo
Derek Davies
View PDFchevron_right
Killing of Kras-Mutant Colon Cancer Cells via Rac-Independent Actin Remodeling by the GBP Cytokine, a Physiological PI3K Inhibitor Therapeutically Effective In Vivo
Derek Davies
Molecular Cancer Therapeutics, 2012
View PDFchevron_right
Therapeutic Discovery Killing of Kras-Mutant Colon Cancer Cells via Rac- Independent Actin Remodeling by the bGBP Cytokine, a Physiological PI3K Inhibitor Therapeutically Effective In Vivo
Fabio Verginelli
2016
View PDFchevron_right
Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer
Paul Grippo
Molecular cancer, 2015
View PDFchevron_right
Mutant PIK3CA-Bearing Colon Cancer Cells Display Increased Metastasis in an Orthotopic Model
Charles Levea
Cancer Research, 2007
View PDFchevron_right
Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition
Helmut Dolznig
International Journal of Molecular Sciences
View PDFchevron_right
An active Src kinase-[beta]-actin association is linked to actin dynamics at the periphery of colon cancer cells
Egle Avizienyte
Experimental cell …, 2007
View PDFchevron_right
An active Src kinase-β-actin association is linked to actin dynamics at the periphery of colon cancer cells
Tony Ng
Experimental Cell Research, 2007
View PDFchevron_right
PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells
José Morgado-díaz
Journal of Cancer Research and Clinical Oncology, 2010
View PDFchevron_right
Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer
Iram Fatima
Journal of Proteomics, 2017
View PDFchevron_right
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer
Wei Chen
PLoS ONE, 2011
View PDFchevron_right
The Actin-Cytoskeleton Pathway and Its Potential Role in Inflammatory Bowel Disease-Associated Human Colorectal Cancer
Ziad Kanaan
Genetic Testing and Molecular Biomarkers, 2010
View PDFchevron_right
Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3
François Auger, Nicolas Porquet
BMC Cancer, 2011
View PDFchevron_right
Knockdown of PAK4 or PAK1 Inhibits the Proliferation of Mutant KRAS Colon Cancer Cells Independently of RAF/MEK/ERK and PI3K/AKT Signaling
Andrew J Massey
Molecular Cancer Research, 2013
View PDFchevron_right
Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers
Eugene Lifshits
Journal of Clinical Investigation, 2011
View PDFchevron_right
Tumor promotion by γ and suppression by β non-muscle actin isoforms
Павел Копнин, Vera B Dugina
Oncotarget, 2015
View PDFchevron_right
Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma
Dr Savio George Barreto
World Journal of Gastroenterology, 2014
View PDFchevron_right
Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation
Brian Blair
Cancer Research, 2013
View PDFchevron_right
NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells
Kai Lee Yap
Cancer Research, 2012
View PDFchevron_right
Modulation of actin dynamics as potential macrophage subtype-targeting anti-tumour strategy
Stephan Hüttel
Scientific Reports, 2017
View PDFchevron_right
Activin Signaling in Microsatellite Stable Colon Cancers Is Disrupted by a Combination of Genetic and Epigenetic Mechanisms
Jessica Gómez
PLOS One, 2009
View PDFchevron_right
Rapid activation of FAK/mTOR/p70S6K/PAK1-signaling controls the early testosterone-induced actin reorganization in colon cancer cells
Saud Alarifi
View PDFchevron_right
Investigation of the effects of drugs effective on PI3K-AKT signaling pathway in colorectal cancer alone and in combination
Nergiz Turgut
Cumhuriyet Medical Journal, 2014
View PDFchevron_right
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
mimmo turano
Journal of Experimental & Clinical Cancer Research
View PDFchevron_right